MedCity News

Emulate CEO shares the organ-chip maker’s vision to understand and predict drug response

Emulate is the leading provider of next generation in vitro biological models. Researchers use their organ-on-a-chip technology to understand and predict drug response with greater precision and ...
FierceBiotech

Emulate upgrades intestinal organ-on-a-chip for exploring inflammatory bowel disease

Organ-on-a-chip maker Emulate has launched an upgraded offering for researchers studying inflammatory bowel disease with its tissue model that helps illustrate how immune cells are activated and ...
Yahoo Finance

Emulate Launches AVA™ Emulation System to Accelerate Drug Development With First-of-its-Kind High-Throughput Organ-Chip Platform

Emulate, Inc., the world leader in Organ-on-a-Chip technology, today announced the commercial launch of the AVA™ Emulation System , a self-contained instrument that cultures, incubates, and images up ...
The Manila Times

EMulate Therapeutics, Inc. Announces Peer-Reviewed Publication Demonstrating its Paclitaxel ulRFE® Signal to Extend Survival and Slow Tumor Growth in Diffuse Midline Glioma ...

New study published in Journal of Electromagnetic Biology and Medicine provides additional validation for Company’s technology and business model ...
Business Wire

Emulate Closes $82 Million Series E Financing to Scale Amid Rapid Growth in Organ-on-a-Chip Market

BOSTON--(BUSINESS WIRE)--Emulate, Inc., a leading provider of next generation in vitro models, today announced the close of an $82 million Series E financing round led by existing investor Northpond ...
MD&M East

Emulate's Organ-on-Chip Technology in the 2nd Inning, Still Has Room to Grow

Emulate has raised $82 million in a series E round to help further develop and commercialize its organ-on-a-chip technology. The Boston, MA company has raised a total of $225 million since it was ...
STAT

‘Organ-on-a-chip’ maker Emulate names new CEO, announces new funding

A Boston startup known for its plastic chips that simulate human organs announced the appointment of a new CEO on Thursday as it ramps up its commercial portfolio with new funding. Jim Corbett will ...
Business Wire

Emulate Announces New Gene Therapy Application Enabling Accelerated Development of Treatments for Genetic Diseases with Organ-on-a-Chip Technology

BOSTON--(BUSINESS WIRE)--Emulate, Inc., a leading provider of next-generation in vitro models, today announced the launch of its new adeno-associated virus (AAV) transduction application for the Liver ...
The Scientist

Emulate, Inc. Unveils the Chip-R1™ Rigid Chip with a Minimally Drug-Absorbing Profile to Improve Biological Modeling for ADME and Toxicology Applications

Emulate, Inc., the leading provider of next-generation in vitro Organ-Chip models, today announced the release of its new Chip-R1™ Rigid Chip, designed to minimize drug absorption and enhance ...
Seeking Alpha

Medical device developer Emulate Therapeutics sets terms for proposed $13M IPO

Medical device maker Emulate Therapeutics (EMTX) has set terms for a proposed IPO that would raise around $13M. Emulate said in a filing that it is looking to offer 2.5M shares priced between $4 and ...
SpaceNews

Emulate Brain-Chip to Study the Effects of Microgravity on Human Brain Physiology at the International Space Station

Emulate, Inc., a leading provider of next-generation in vitro models, today announced that the Brain-Chip is being sent to the International Space Station U.S. National Laboratory (ISS National Lab) ...